
Euroapi Investor Relations Material
Latest events

AGM 2025
Euroapi
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Euroapi S.A.
Access all reports
Euroapi S.A., operating under the brand EUROAPI, is a global leader in the production of active pharmaceutical ingredients (APIs). The company boasts an extensive portfolio of over 200 products, serving the healthcare industry by developing, manufacturing, and distributing APIs and intermediates. These ingredients are crucial for the formulation of medicines intended for both human and veterinary use, catering to a broad spectrum of therapeutic areas including small molecules, lipids, microbial fermentation, and more. EUROAPI's offerings also encompass Contract Development and Manufacturing Organization (CDMO) services. The company is headquartered in Paris, France, and its shares are listed on the Euronext Paris stock exchange.
Key slides for Euroapi S.A.


H1 2024
Euroapi S.A.


H2 2024
Euroapi S.A.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
EAPI
Country
🇫🇷 France